Advertisement
Screener

OCUGEN, INC. (OCGN) ROI

OCUGEN, INC. (OCGN) ROI

  • 2026-06-30: ROI 552.52%.
  • 2026-03-31: ROI -204.79%.
  • 2025-12-31: ROI -408.07%.
  • 2025-09-30: ROI -200.48%.

Complete source-backed roi history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-30552.52%
2026-03-31-204.79%
2025-12-31-408.07%
2025-09-30-200.48%
2025-06-30-183.22%
2025-03-31-131.89%
2024-12-31-92.71%
2024-09-30-117.53%
2024-06-30-252.17%
2024-03-31-174.30%
2023-12-31-145.46%
2023-09-30-141.71%
2023-06-30-136.67%
2023-03-31-120.68%
2022-12-31-107.26%
2022-09-30-84.13%
2022-06-30-58.05%
2022-03-31-54.47%
2021-12-31-62.82%
2021-09-30-43.72%
2021-06-30-40.05%
2021-03-31-51.38%
2020-12-31-92.44%
2020-09-30-32.15%
2020-06-30-86.67%
2019-12-31-167.42%
2018-12-31432.93%

Annual ROI

DateROI
2025-12-31-408.07%
2024-12-31-92.71%
2023-12-31-145.46%
2021-12-31-62.82%
2020-12-31-92.44%
2019-12-31-167.42%
2018-12-31432.93%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
AGENUS INC (AGEN)United States$0.383B1.41
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Surrozen, Inc./DE (SRZN)United States$0.395B